A10BB01 • glibenclamide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas
Glibenclamide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.
It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glibenclamide is effective in reducing the risk of diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).
Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, weight gain, dizziness, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.
Substance: glibenclamide
Date of last drug list: 10-04-2026
Commercial code: W41858003
Concentration: 1.75mg
Pharmaceutical form: tablets
Quantity: 30
Product type: generic
Price: 2.60 RON
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: ARENA GROUP S.A. - ROMANIA
Holder: ARENA GROUP S.A. - ROMANIA
Number: 12120/2019/01
Shelf life: 3 years